Q3 2022 · 13F-HR
CHI Advisors LLCholdings as filed
Filed 2022-11-09 · accession 0001085146-22-003844
$371,907
Reported value
25
Positions
2022-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74349U108 | — | PROMETHEUS BIOSCIENCES INC | $94,521 | 25.4% | 1,601,785 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $71,230 | 19.2% | 3,409,758 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $41,578 | 11.2% | 3,243,185 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $37,237 | 10.0% | 3,069,847 | Common | SOLE |
| H9060V101 | — | VECTIVBIO HLDG AG | $24,717 | 6.65% | 4,119,572 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $15,178 | 4.08% | 1,762,793 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $10,928 | 2.94% | 3,415,148 | Common | SOLE |
| 00973J101 | — | AKOUOS INC | $8,709 | 2.34% | 1,288,358 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $7,715 | 2.07% | 530,223 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $7,533 | 2.03% | 200,229 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $6,452 | 1.73% | 2,829,712 | Common | SOLE |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $5,723 | 1.54% | 1,055,882 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $5,350 | 1.44% | 1,996,277 | Common | SOLE |
| 74019P108 | — | PRECISION BIOSCIENCES INC | $4,777 | 1.28% | 3,674,820 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $4,311 | 1.16% | 1,214,304 | Common | SOLE |
| 3621LQ109 | GTHXEUR | G1 THERAPEUTICS INC | $4,046 | 1.09% | 323,945 | Common | SOLE |
| 68570P101 | — | ORCHARD THERAPEUTICS PLC | $3,994 | 1.07% | 7,987,396 | Common | SOLE |
| 28249U105 | CLDNEUR | EIGER BIOPHARMACEUTICALS INC | $3,427 | 0.92% | 455,100 | Common | SOLE |
| 35655L107 | — | FREELINE THERAPEUTICS HLDGS | $3,370 | 0.91% | 4,814,419 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $2,811 | 0.76% | 194,297 | Common | SOLE |
| 68236R103 | — | ONCORUS INC | $2,012 | 0.54% | 2,367,436 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $1,952 | 0.52% | 2,384,402 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $1,591 | 0.43% | 864,822 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $1,548 | 0.42% | 117,599 | Common | SOLE |
| 25460G716 | LABDUSD | DIREXION SHS ETF TR | $1,197 | 0.32% | 50,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.